Keyphrases
Beta-blockers
100%
Angiotensin
100%
Reduced Ejection Fraction
100%
Renin-angiotensin System Inhibitors
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
66%
Angiotensin Receptor Blockers
66%
Body Mass Index
50%
Odds Ratio
50%
Confidence Interval
50%
Up-titration
50%
Left Ventricular Ejection Fraction
33%
Community-based
16%
Obesity
16%
High Body Mass Index
16%
Type 1 Diabetes Mellitus (T1DM)
16%
Heart Failure Patients
16%
Heart Failure
16%
Recommended Dose
16%
Age at Presentation
16%
Gestational Diabetes Mellitus
16%
Suboptimal Dose
16%
Society Guidelines
16%
Heart Failure Clinic
16%
Low beta
16%
Medicine and Dentistry
Angiotensin
100%
Ejection Fraction
100%
Beta Adrenergic Receptor Blocking Agent
100%
Renin Inhibitor
100%
Body Mass Index
66%
Angiotensin Receptor Antagonist
66%
Odds Ratio
50%
Heart Failure
50%
ACE Inhibitor
50%
Titrimetry
50%
Diabetes Mellitus
33%
Heart Left Ventricle Ejection Fraction
33%
Outpatient
16%
Recommended Drug Dose
16%
Optimal Drug Dose
16%
Biochemistry, Genetics and Molecular Biology
Renin-Angiotensin
100%
Heart Ejection Fraction
100%
Beta Blocker
100%
Body Mass
66%
Angiotensin Receptor
66%
Enzyme Inhibitor
50%
Angiotensin-Converting Enzyme
50%
Heart Left Ventricle Ejection Fraction
33%
Optimal Drug Dose
16%
Recommended Drug Dose
16%
Neuroscience
Angiotensin
100%
Beta Blocker
100%
Renin Inhibitor
100%
Body Mass Index
66%
Angiotensin Receptor
66%
ACE Inhibitor
50%
Diabetes Mellitus
33%